Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junqi Niu

Showing results (131-140 of 280) with videos related to

Pageof 28
Sort By:
BMJ Open|December 1, 2018
Association of IL-10 and IL-10RA single nucleotide polymorphisms with the responsiveness to HBV vaccination in Chinese infants of HBsAg(+)/HBeAg(-) mothers: a nested case-control studySimin Wen, Yanhua Wu, Yuchen Pan, et al.
International Immunopharmacology|June 24, 2016
IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid:polycytodylic acidXiaoli Pang, Zhaoxia Wang, Naicui Zhai, et al.
Virology Journal|January 7, 2021
Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatmentXiaomei Wang, Xiumei Chi, Ruihong Wu, et al.
British Journal of Clinical Pharmacology|November 19, 2016
Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infectionYanhua Ding, Jinfeng Lou, Hong Chen, et al.
Viruses|September 28, 2021
HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-InfectionImme Roggenbach, Xiumei Chi, Florian A Lempp, et al.
Antimicrobial Agents and Chemotherapy|July 19, 2021
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Capsid Assembly Modulator GST-HG141 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation TrialCuiyun Li, Min Wu, Hong Zhang, et al.
Nano Research|October 31, 2022
Thermal-annealing-regulated plasmonic enhanced fluorescence platform enables accurate detection of antigen/antibody against infectious diseasesYing Yue, Jingjie Nan, Yuanyuan Che, et al.
Plos One|May 22, 2015
Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinomaXiuying Liu, Xiumei Chi, Qiaoling Gong, et al.
Clinical Proteomics|January 17, 2015
LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patientsXia Zou, Xiumei Chi, Yu Pan, et al.
Infection and Drug Resistance|October 2, 2019
Computational analysis of naturally occurring resistance-associated substitutions in genes <i>NS3</i>, <i>NS5A</i>, and <i>NS5B</i> among 86 subtypes of hepatitis C virus worldwideRuihong Wu, Dongfeng Geng, Xiumei Chi, et al.
Pageof 28

Showing results (131-140 of 280) with videos related to

Sort By:
Pageof 28
BMJ Open|December 1, 2018
Association of IL-10 and IL-10RA single nucleotide polymorphisms with the responsiveness to HBV vaccination in Chinese infants of HBsAg(+)/HBeAg(-) mothers: a nested case-control studySimin Wen, Yanhua Wu, Yuchen Pan, et al.
International Immunopharmacology|June 24, 2016
IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid:polycytodylic acidXiaoli Pang, Zhaoxia Wang, Naicui Zhai, et al.
Virology Journal|January 7, 2021
Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatmentXiaomei Wang, Xiumei Chi, Ruihong Wu, et al.
British Journal of Clinical Pharmacology|November 19, 2016
Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infectionYanhua Ding, Jinfeng Lou, Hong Chen, et al.
Viruses|September 28, 2021
HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-InfectionImme Roggenbach, Xiumei Chi, Florian A Lempp, et al.
Antimicrobial Agents and Chemotherapy|July 19, 2021
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Capsid Assembly Modulator GST-HG141 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation TrialCuiyun Li, Min Wu, Hong Zhang, et al.
Nano Research|October 31, 2022
Thermal-annealing-regulated plasmonic enhanced fluorescence platform enables accurate detection of antigen/antibody against infectious diseasesYing Yue, Jingjie Nan, Yuanyuan Che, et al.
Plos One|May 22, 2015
Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinomaXiuying Liu, Xiumei Chi, Qiaoling Gong, et al.
Clinical Proteomics|January 17, 2015
LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patientsXia Zou, Xiumei Chi, Yu Pan, et al.
Infection and Drug Resistance|October 2, 2019
Computational analysis of naturally occurring resistance-associated substitutions in genes <i>NS3</i>, <i>NS5A</i>, and <i>NS5B</i> among 86 subtypes of hepatitis C virus worldwideRuihong Wu, Dongfeng Geng, Xiumei Chi, et al.
Pageof 28